Uma rota conveniente para a síntese de 3β-hidroxi-6-oxo-5α-esteroides a partir de ∆ 5 -esteroides é descrita tendo sido aplicada para a síntese da laxogenina, substância que apresenta atividade como hormônio de crescimento vegetal. O método é uma alternativa para instalar este grupo funcional importante encontrado em esteróides naturais. O processo descrito utiliza reagentes baratos e pode ser executado em quatro etapas. As etapas de oxidação e de tratamento ácido não afetam a cadeia lateral espirocetálica presente na diosgenina (16).
Introduction
The 3β-hydroxy-6-oxo moiety is present in different naturally occurring steroids. 1 The brassinosteroid teasterone (1), 2 the steroid glycoside osladin (2), 3 lactones as chiogralactone (3) 4 and dendrosterone (4), 5 and steroidal alkaloids like petisidine (5) 6 and petisine (6) 7 are some examples of naturally occurring steroids bearing such functionality ( Figure 1) .
Recently, we have synthesized laxogenin (7), a steroidal sapogenin isolated from Smilax sieboldi 8 and its C-23 substituted derivatives 8 and 9 and reported that they have shown plant growth promoting activity similar of that of brassinosteroids ( Figure 2 ). 8 In that report, a protocol based on Brown´s hydroboration for the introduction of the 3β-hydroxy-6-oxo moiety was developed.
The 5β,6β-epoxy moiety has been previously used for the preparation of 6-oxosteroids. In particular, Henbest and Wrigley reported 9 that treatment of 5,6β-epoxy-5β-cholestan-3β-ol acetate with BF 3 ·Et 2 O led to the corresponding 3β-acetoxy-5-fluoro-6β-hydroxy-5α-steroid which was oxidized to 3β-acetoxy-5-fluoro-5α-cholestan-6-one using Jones reagent. More recently, an extension of this procedure to stigmasterol has been used to obtain brassinosteroid analogues bearing the 5α-fluoro-6-oxo moiety. 9 Owing our interest on steroids bearing such functionality, and after some reports on the highly stereoselective β-epoxidation of ∆ 5 -steroids using biphasic systems involving potassium permanganate and metal salts, 10 we envisaged the β-epoxidation of the C5-C6 double bond followed by the regioselective oxirane ring opening as the key steps for the introduction of an oxygen atom at position C-6. This led us to an alternative protocol for the synthesis of 3β-hydroxy-6-oxo steroids.
Fe 2 (SO 4 ) 3 resulted in the highly diasteroselective β-epoxidation of the C5-C6 double bond; only traces of the α-epoxide could be detected in the 1 H NMR spectra. Regioselective opening of the β-oxirane ring with aq. HBr led to the bromohydrin 11 as sole product.
Treatment of the bromohydrin 12 with Jones reagent, supported on silica gel, led the bromoketone 13 (Scheme 1). In this way, manipulation of the reaction was rapidly effectuated and permitted a better treatment for wastes.
We also studied this three-reaction sequence without isolation of the intermediate epoxide 11 and bromohydrin 12; this resulted in a very fast and convenient protocol for the conversion of cholesteryl acetate into the bromoketone 13 (75% overall yield for the consecutive three steps). Treatment of 13 with zinc in refluxing acetic acid yielded the acetylated ketone 14, which on saponification afforded the desired 3β-hydroxy-5α-cholestan-6-one (15). The same one-pot synthetic sequence was applied to diosgenin acetate (16) to produce laxogenin (7). Under these strong oxidizing and acidic media, the labile spiroketal side chain of diosgenin resulted unchanged (Scheme 2).
Experimental
NMR spectra were registered in CDCl 3 on a Varian Mercury spectrometer at 400 MHz for 1 H or 100 MHz for 13 C. Chemical shifts (δ) are expressed on ppm downfield from TMS. Melting points were obtained on a Gallenkamp MFB 595 apparatus and were not corrected.
5,6β-Epoxy-5β-cholestan-3β-ol acetate (11)
KMnO 4 (2 g) and Fe 2 (SO 4 ) 3 .nH 2 O (1 g) were finely grounded in a mortar, H 2 O (0.2 mL) was added and the mixture was placed in a round bottom flask containing CH 2 Cl 2 (5 mL). A solution of cholesteryl acetate (10) (428 mg, 1 mmol) in CH 2 Cl 2 (5 mL) was added followed by addition of tert-butyl alcohol (0.5 mL). After 20 min of stirring at room temperature, the mixture was filtered through a pad of celite, and eluted with 30 mL of CH 2 Cl 2 . The crude filtrate was washed with H 2 O (5x15) mL, dried (anhydrous Na 2 SO 4 ) and evaporated to afford 427 mg (96%) of the desired epoxide 11; mp 110-111 ºC, lit. 
5-Bromo-5α-cholestan-3β,6β-diol 3-acetate (12)
A solution of the epoxide 11 (445 mg, 1 mmol) in CH 2 Cl 2 (15 mL) was vigorously shaken for 5 min in a separatory funnel with 5 mL of 48% HBr. The organic layer was washed with H 2 O (5x 15 mL), dried (anh. Na 2 SO 4 ) and evaporated to afford 510 mg (97%) of the bromohydrin 12; mp 174-175 ºC, lit. 
3β-Acetoxy-5-bromo-5α-cholestan-6-one (13)
A mixture of Jones reagent (2.5 mL) and silica gel (5 g) was stirred until an homogeneous orange powder was formed. CH 2 Cl 2 (15 mL) was added followed by the addition of a solution of the bromohydrin 12 (526 mg, 1 mmol) in CH 2 Cl 2 (10 mL); the mixture was stirred for 20 min, filtered through an small pad of silica gel and the eluent was evaporated to afford 414 mg (79%) of the bromoketone 13; mp 157-158 ºC (decomp.), lit. 13 
3β-Acetoxy-5-bromo-5α-cholestan-6-one (13) via a three steps procedure: β-epoxidation, oxirane-opening, alcoholoxidation
KMnO 4 (6 g) and Fe 2 (SO 4 ) 3 .nH 2 O (3 g) were finely grounded in a mortar, H 2 O (0.6 mL) was added and the mixture was placed in a round bottom flask containing CH 2 Cl 2 (45 mL). A solution of cholesteryl acetate (10) (1.284 g, 3 mmol) in CH 2 Cl 2 (45 mL) was added followed by addition of tert-butyl alcohol (1.5 mL). After 20 min of stirring at room temperature, the mixture was filtered through a pad of celite and eluted with 30 mL of CH 2 Cl 2 . The crude filtrate was washed with H 2 O (5x25 mL) and vigorously shaken for 5 min in a separatory funnel with 15 mL of 48% HBr, washed with H 2 O (5x 30 mL) and added to a stirred mixture of silica gel-supported Jones Reagent (prepared from 2.5 mL of Jones reagent and 5 g silica gel as described for the oxidation of 12) and CH 2 Cl 2 (30 mL). The mixture was stirred for 20 min, filtered through a small pad of silica gel and the eluent was evaporated to afford 1.178 mg (75%) of the bromoketone 13, identical as described above.
3β-Acetoxy-5α-cholestan-6-one (14)
A mixture of the bromoketone (524, 1 mmol), zinc powder (262 mg, 4 mmol) and acetic acid (10 mL) was stirred under reflux for 2 h. AcOEt (50 mL) was added and the mixture was washed with saturated NaCl solution (5x15 mL), 10% NaHCO 3 solution (3x20 mL) and H 2 O (5x15 mL). The organic layer was dried with Na 2 SO 4 13 3β-Hydroxy-5α-cholestan-6-one (15) A mixture of the acetylated ketone 14 (445 mg, 1 mmol), KOH (0.5 g) and MeOH (50 mL) was gently warmed for 15 min, H 2 O (15 mL) was added, most of the MeOH was evaporated and the mixture was extracted with AcOEt (2x20 mL). The organic layer was washed with brine (3x15 mL) and H 2 
